Sage Journals: Discover world-class research

Abstract

Researchers are increasingly focused on the nanoscale level of organization where biological processes take place in living systems. Nanoparticles (NPs, e.g., 1–100 nm diameter) are small forms of natural or manufactured source material whose properties differ markedly from those of the respective bulk forms of the “same” material. Certain NPs have diagnostic and therapeutic uses; some NPs exhibit low-dose toxicity; other NPs show ability to stimulate low-dose adaptive responses (hormesis). Beyond dose, size, shape, and surface charge variations of NPs evoke nonlinear responses in complex adaptive systems. NPs acquire unique size-dependent biological, chemical, thermal, optical, electromagnetic, and atom-like quantum properties. Nanoparticles exhibit high surface adsorptive capacity for other substances, enhanced bioavailability, and ability to cross otherwise impermeable cell membranes including the blood-brain barrier. With super-potent effects, nano-forms can evoke cellular stress responses or therapeutic effects not only at lower doses than their bulk forms, but also for longer periods of time. Interactions of initial effects and compensatory systemic responses can alter the impact of NPs over time. Taken together, the data suggest the need to downshift the dose-response curve of NPs from that for bulk forms in order to identify the necessarily decreased no-observed-adverse-effect-level and hormetic dose range for nanoparticles.

Keywords

nanoparticle hormesis nanomedicine nonlinear dynamics complex adaptive systems

INTRODUCTION

Nanoparticles (NPs) are very small particles of material that may be natural or manufactured in origin (Buzea et al., 2007; Ju-Nam and Lead, 2008; Merisko-Liversidge and Liversidge, 2011; Roduner, 2006). Sizes typically range from a fraction of one nanometer (nm) in diameter on at least one side up to 100 nanometers (European Commission on the Environment, 2011; International Organization for Standardization, 2005). Although submicron particles between 100–1000 nanometers in size have some advantages toward improving drug delivery (Oyewumi et al., 2010; Stovbun et al., 2012; Wong, 2011), much of the focus of research interest in NPs has been on particles whose size falls below 100 nm. Their small size leads to a large surface area to volume ratio, resulting in variations of properties that differ markedly from those of bulk forms of the “same” material (Buzea et al., 2007; Cao and Wang, 2011; Roduner, 2006).

The range of these altered effects encompasses electromagnetic, thermal, optical, biochemical, and even quantum (in quantum dots, at extremely small particle sizes, typically ranging from 1–10 nm, perhaps as high as 30 nm) properties. Smaller NPs readily cross cell membranes and translocate around the body via blood and lymph (Buzea et al., 2007). Some NPs such as nano-silica or nano-silicon (Demento et al., 2009; Mahony et al., 2013; Petkar et al., 2011; Wang et al., 2012b) and nano-lipid carriers can also serve as immune adjuvants and markedly lower the amount of antigen needed to mount a response in the immune system, e.g., in one study to a dose as low as 2.5 nanograms (Bershteyn et al., 2012; Diwan et al., 2004).

In effect, nanoparticles are often biologically super-potent forms of their source material. For instance, the NP form of an antiretroviral drug in the 3 nanomolar range produced up to a 50-fold reduction in the 50% inhibitory concentration needed, compared with free drug doses (Chaowanachan et al., 2013). Intermittent treatment with the nano-form of the immunosuppressant drug mycophenolic acid improves murine allograft survival time at a dose 1000-fold lower than the bulk form conventional drug (Shirali et al., 2011). By extension, the therapeutic hormetic nanoparticle dose of an otherwise highly toxic source material might fall below the nanomolar level (Raja et al., 2013), e.g., down to picomolar or even lower levels. Some studies further indicate the possibility of sinusoidal hormetic dose-response curves in such a situation (Malarczyk et al., 2011).

Contemporary nanotechnology can generate manufactured nanoparticles in either a top down (e.g., milling, grinding) or bottom up (e.g., nano-silica self-assembly on a structural template) manner (Cho et al., 2011; Cumbo et al., 2013; Ju-Nam and Lead, 2008; Kiel et al., 2012; Merisko-Liversidge and Liversidge, 2011). Reagents and manufacturing parameters such as solvents, dopants, coatings, biosynthetic plant extracts, pH, temperature, and sonication duration and intensity can influence the biological, chemical, electromagnetic, optical and physical properties of the resultant NPs (Cao and Wang, 2011; Pandey et al., 2013; Roduner, 2006). Various nanoparticles will aggregate in the absence of capping agents and/or mechanical dispersion methods (Mudunkotuwa and Grassian, 2011; Pandey et al., 2013; Pham et al., 2007; Tang et al., 2011; Zhang et al., 2012).

APPLICATIONS IN MEDICINE AND TOXICOLOGY

In medicine, NPs have a growing importance for pharmacodiagnostics and therapy (Ahn RW, 2013; Armstead and Li, 2011; Ho and Leong, 2010; Stark, 2011; Yoo et al., 2011) as well as toxicology (Buzea et al., 2007; Winnik and Maysinger, 2013). Exemplar medical applications of nano-forms are the enhanced drug or natural product delivery vehicles with increased bioavailability and cell targeting potential in infectious diseases (Armstead and Li, 2011; Dar et al., 2013) and cancers (Al-Sadoon et al., 2012; Chu et al., 2012; Ghosh et al., 2012; Sayed et al., 2012; Shi et al., 2010b; Wang and Thanou, 2010).

In the emerging area of theranostics, specialized nano-drugs enable more precise targeting of specific cells and/or organs (Vivero-Escoto et al., 2010). For instance, magnetic nanoparticle vehicles can be activated to release their active agent for imaging and/or treatment only after they enter their intended specific cancer cell target (Cole et al., 2011; Ho et al., 2011). The latter approach can take advantage of the nonlinear magnetic behavior of the NPs (Geinguenaud et al., 2012). Nonlinearity of response can derive in part from the unique magnetic or optical properties of certain NPs. For example, near infrared light-activated cell-targeted nanoparticles can augment photothermal ablation therapies (Melancon et al., 2011). However, continuous wave versus nanosecond pulsed laser stimuli can interact with nonlinear absorption processes of gold nanospheres from plasmonic field enhancement to produce different cell death mechanisms in the cancer cell nucleus versus cytoplasm (Huang et al., 2010).

Overall, NPs can more readily enter cancer cells because of the increased vascular leakiness of tumors resulting in passive and/or active uptake processes from ligands on the NP surfaces (Ghosh et al., 2012; Sur et al., 2010). Advantages of nano drug delivery vehicles with targeting include a significant reductions of systemic toxicity in addition to lowering total doses by orders of magnitude (Ahmad et al., 2006; Armstead and Li, 2011; Prakash et al., 2010; Shirali et al., 2011).

In environmental toxicology, high doses of many, though not all, nanoparticles appear to be toxic and potentially contributory to a wide range of diseases, from asthma to autoimmune diseases or atherosclerosis and cancer (Buzea et al., 2007; Winnik and Maysinger, 2013). Even extremely low concentrations of nanoparticles of a given substance can still exert toxic effects on model organisms e.g., 1 nanomolar ceria NPs on C. elegans (Zhang et al., 2011), sublethal adverse effects from 0.02 to 0.20 nanomolar silver NPs or 0.025 to 1.2 nanomolar gold NPs on developing zebrafish embryos (Browning et al., 2009; Lee et al., 2012b; Osborne et al., 2012; Truong et al., 2013), or 20 nanograms/L silver NPs on juvenile salmon (Farmen et al., 2012). Across studies, silver NPs are overall more toxic than gold NPs, but many particle- and organism-related variables affect the specific findings. NP toxicity can derive from activating oxidative stress, inflammatory, immune and even apoptotic pathways as well as genotoxicity in cells (Gualtieri et al., 2011; Sandberg et al., 2012; Shi et al., 2010a; Shi et al., 2010b; Winnik and Maysinger, 2013). Plant-mediated biosynthesis of silver NPs can attenuate toxicity risk in some preparations (Barua et al., 2013). One of the major questions that this heightened sensitivity from NPs asks is whether or not NPs violate the no-observed-adverse-effect level (NOAEL) principle of hormesis or is the NOAEL of NPs simply down-shifted to lower levels and modified by the specific properties of a given NP form than with larger and bulk form particles?

HORMESIS AND NANOPARTICLES

At very low doses below the no-observed-adverse-effect level (NOAEL), previous investigators have documented evidence that some nanoparticles can initiate hormesis (Iavicoli et al., 2010; Nascarella and Calabrese, 2012; Stovbun et al., 2012). Hormesis is the nonlinear dose-response relationship in which low versus high doses of a given agent or stressor can exert effects in opposite directions. If an agent can inhibit function at a high dose, then the hormetic dose will stimulate function, and vice versa. Hormesis is increasingly understood as a dynamic adaptive response or biological plasticity of a complex living system at the level of the whole organism to intermittent mild stressors of various categories (Calabrese, 2013; Calabrese and Mattson, 2011; Iavicoli et al., 2010). Types of stressor categories include physical, chemical, biological, and/or psychological factors (Calabrese and Mattson, 2011; Iavicoli et al., 2010). Calabrese and Mattson (2011) have used hormesis as a quantitative estimate of biological plasticity.

For therapeutic applications, other researchers have proposed that exposing organisms to intermittently-timed hormetic stimuli could shift and shape epigenetic expression toward increased resilience against higher intensity stressors, disease, and aging itself (Stark, 2012; Vaiserman, 2010, 2011). Pickering et al (2013) have emphasized the importance of spacing repeated exposures over time to permit expression of adaptive changes to oxidative stress. The beneficial effects of hormesis may arise from endogenous over-compensatory changes that the cell and organism use to repair or prepare for damage from larger magnitude, adaptively similar external threats from the environment (Stark, 2012; Van Wijk and Wiegant, 2010; Wiegant et al., 2011).

The literature on cross-adaptation, cross-resistance and cross-sensitization includes many examples of overlapping phenomena that emphasize the role of biological plasticity mechanisms and time-dependent mechanisms in the organism. Pathways for the stress response networks involve interactions of metabolic, immune, inflammatory, hormonal, and autonomic functions. Thus, the biology of adaptation is an emergent property of the organism as a whole and distinct from any local chemical effects of the exogenous agent on its specific receptors (see Figure 1). Sub-toxic and sub-lethal stressors initiate adaptive changes that can prepare the organism for future onslaughts from both the original stressor and agents where the physical nature, but not the elicited adaptive response repertoire of the recipient system, differs from that of the original (Milisav et al., 2012). These latter types of responses are sometimes termed cross-adaptation (Hale, 1969) or cross-resistance (Milisav et al., 2012) and, in other cases, heterologous hormesis (Calabrese et al., 2007; Van Wijk and Wiegant, 2010).

FIGURE 1.

Dual Pathways for Exogenous Agents, including Nanoparticles, as Ligands and Stressors.

However, there is a potentially important distinction for a specific agent and its dose or intensity level as a stressor for an individual organism. That is, some agents such as arsenic are relatively toxic and even lethal for most organisms at what pharmacologists consider low doses for their local effects. In that case, looking to a very low dose range might reveal a beneficial hormetic dose range for their adaptation-stimulating effects in most organisms. Thus, it makes sense to look for hormesis at extremely low doses of bulk form arsenic (Raja et al., 2013) and perhaps even lower doses of nano-arsenic trioxide (Ahn et al., 2013). Other nanomaterials such as nano-calcium hydroxyapatite may be largely benign across a wider range of dose levels (Zhou and Lee, 2011) and/or can safely deliver nano-forms of less toxic agents for greater bioavailability and clinical benefit than reliance on more toxic bulk form drugs (Chun et al., 2012; Joshi and Muller, 2009; Koning and Krijger, 2007; Lanao et al., 2007; Moulari et al., 2013; Zhao and Feng, 2010).

By analogy, for other types of more benign stressors such as exercise in physiology, the reaction to exercise as a “stressor” will also depend on the pre-established level of physical training and fitness of the individual. In general, exercise is not an inherently toxic event – rather, it is part of the physiological capacity of the organism. Nonetheless, an exercise level that may be moderate for a highly fit person could even be lethal for a poorly-conditioned individual. Many doses of exercise may be fairly benign and initiate adaptive changes consistent with training effects. The “dose” of exercise that is beneficial will thus vary as a function of individual differences in the state of the organism at the time of the exercise. Genetic variations (Rodriguez et al., 2012) and other environmental parameters (Lagisz et al., 2013) can also influence individual differences in dose-response patterns for a variety of events and agents.

Certain NPs pose an additional challenge for determination of the no-observed-adverse-effect level (NOAEL) cut-off. In a complex nonlinear paradox, lower doses of NPs can sometimes increase rather than decrease the toxicity of a given source material as a function of the surface properties of the particles themselves. That is, in the absence of surface modifications to prevent spontaneous agglomeration from close physical interactions of highly reactive NPs in concentrated colloidal liquids (Bagwe et al., 2006; Clark et al., 2010; Sur et al., 2012), higher concentrations or doses can favor NP agglomeration. The resultant nanoaggregates as a whole then can hide or quench the originally hyperreactive surfaces of their smaller NP “parts” (Mudunkotuwa and Grassian, 2011). Consequently, the specific larger agglomerated NP form is less toxic at a higher concentration than a lower dose of smaller, but well-dispersed NPs, e.g., NPs of PbS or copper.

For environmental toxicology, various forms of agitation, together with natural dilution factors that reduce concentration in the marine environment, for example, may disperse such agglomerates (Bourdineaud et al., 2013; Rodrigues et al., 2013; Ruan and Jacobi, 2012; Tang et al., 2011; Zhang et al., 2012). In such scenarios, the dispersion at a lower concentration re-exposes the hyperreactive surfaces of the smaller NPs and enhances their toxic potential (Mudunkotuwa and Grassian, 2011).

For nanomedicine applications, it is possible to take advantage of such issues by adding nontoxic capping agents (Singh et al., 2013) and/or to time the use of sonication or vortexing prior to administration. Such a strategy can determine more systematically the nanoparticle size, shape, and surface chemistry. That is, certain capping agents, e.g., sugars or polysaccharides, can markedly reduce metal NP toxicity. Moreover, sonication will mechanically disperse any larger nanostructures that may have formed as a result of aging, agglomeration, and/or Ostwald ripening of the NPs in colloidal solution. In contrast, longer shelf storage over time could permit resumption of aging effects and thermodynamically-based development of increasingly larger nanostructures (Gautam et al., 2013; Liu et al., 2007). Thus, recency of sonication in solution can affect experimental and clinical findings (Bel Haaj et al., 2013; Liu et al., 2009; Murdock et al., 2008; Tang et al., 2011).

Such issues become critical for evaluating NP effects in medicine and toxicology, when size, shape, and surface chemistry interact with dose to determine nonlinear response patterns (Mudunkotuwa and Grassian, 2011). For example, it is possible to reduce macrophage toxicity of antibacterial silver nanoparticles by coating the surfaces with chitosan (Jena et al., 2012). Chitosan is a fibrous sugar extracted from shellfish outer skeletons. NP characteristics also contribute to unique challenges for controlling inter-experiment variability with NPs such as fullerene C60 nanoparticles (Chang and Vikesland, 2013).

What the data on nanomaterials raise for the discussion of hormesis is an analogous need to readjust our thinking about what constitutes a low dose, or more, precisely, a hormetic dose. Beyond the identity of the source material, the specific sizes, shapes, and surface charges of the NPs in air or water become significant factors interacting with dose. Hormesis researchers may need a type of sliding scale for defining very low hormetic doses where adverse events do not occur and yet beneficial adaptive changes can develop. First, the super-potent reactivity of small nanoparticles lowers the dose range for both toxic and, if relevant, therapeutic effects from a pharmacological perspective (Armstead and Li, 2011). Second, nanoparticles of the “same” material at a given low dose can exert either toxic or benign effects, depending in part on the size and surface reactivity of the particles (Lee et al., 2012b; Mudunkotuwa and Grassian, 2011; Murdock et al., 2008; Winnik and Maysinger, 2013).

Third, the coating or dopants on the surfaces of nanoparticles can also markedly change an otherwise toxic particle into a benign one or to acquire modified actions (Das et al., 2013; McKibbin et al., 2013; Rowe et al., 2013; Sur et al., 2012; Sur et al., 2010; Thurber et al., 2012; Tripathi et al., 2009; Van Hoecke et al., 2011). Fourth, the state of the recipient system cell or organism as a complex adaptive system (CAS) at the time of exposure is another modifying variable in the intensity and even direction of the response to nano and bulk form materials (Antelman and Caggiula, 1996; Bell and Schwartz, 2013; Browning et al., 2009; Lee et al., 2012b; Shi et al., 2010b). Finally, NP forms of various source materials, including animal venoms, calcium phosphate, and nanocrystalline fullerene can exert marked toxicity for cancer cells but spare healthy cells (Al-Sadoon et al., 2012; Harhaji et al., 2007; Shi et al., 2010b).

Thus, for nanoparticles, nonlinear hormetic responses are no longer a function of merely specific low doses. It is necessary to take into account the variable toxicity of a given specific nanoparticle based on its potential to change size, and hence, surface charge and related direct effects. The NPs then interact with individual differences in organisms’ ever-changing dynamical state of adaptive resilience to the lower dose ranges of nanoparticles in general. In general, the shift of the toxic dose range for nanoparticle forms of environmental toxicants toward lower doses is also orders of magnitude below that for bulk forms of the “same” materials. By extension, the no-observed-adverse-event-level (NOAEL) for nanoparticles of typically toxic agents must be very low to accommodate the range of various NP sizes and surface chemistries that may emerge within a given environmental context, far below the more fixed NOAEL for bulk forms of the same material (Figure 2). The potential for multiple particle-related, environment-related, and recipient-related factors to contribute variance in determining the NOAEL in each study of a given nanoparticle form make it much more difficult to define an appropriate metric for what constitutes a “low dose” or a hormetic dose.

FIGURE 2.

Left Shift of NOAEL and Hormetic Dose Range for Nanoparticles. Reprinted with permission (Bell and Schwartz, 2013).

Dose frequency also plays a role in adaptive phenomena. Nano-drugs persist inside cells longer than do conventional bulk form drugs (Ahmad and Khuller, 2008; Ahmad et al., 2006; Armstead and Li, 2011; Shirali et al., 2011). Even for bulk forms, with overly frequent dosing of an agent, the direction of the response can reverse when the nature of the response depends on the biological plasticity and metaplasticity mechanisms of adaptation to the agent as a stressor rather than on the mechanisms of its local effects on specific receptors (Abraham, 2008; Antelman and Caggiula, 1996; Antelman et al., 1992; Antelman et al., 2000; Pincus and Metten, 2010). Such data suggest the potential role of pulsed versus continuous dosing in mobilizing compensatory adaptive responses to an exogenous stressor or agent (Milisav et al., 2012; Shirali et al., 2011; Stark, 2012).

In addition, the nature of adaptive responses, as opposed to local ligand-receptor responses, is that the emergent result is increased resistance to the original stressor and cross-resistance or cross-adaptation to other stressors that can affect similar adaptive pathways. In pharmacology and physiology research outside toxicology, many empirical examples of cross-adaptation, cross-resistance and cross-sensitization are documented (Antelman et al., 1992; Antelman et al., 2000; Hale, 1969; Milisav et al., 2012). For instance, hypoxia cross-adapts with cold or hot temperatures (Banti et al., 2008; Launay et al., 2006; Lunt et al., 2010; Ning and Chen, 2006); stress cross-sensitizes with amphetamine (Antelman et al., 1980); sucrose cross-sensitizes with amphetamine or cocaine (Avena and Hoebel, 2003; Gosnell, 2005); formaldehyde cross-sensitizes with cocaine (Sorg et al., 2001; Sorg et al., 1998); heat shock, sodium arsenite, and cadmium chloride can cross-sensitize with one another depending on their heat shock protein activation patterns (Wiegant et al., 1998).

The inference from such evidence is that an external agent at various doses is a salient biological stressor for the cell or organism as a complex adaptive system in addition to the local, receptor-specific actions (Bell and Schwartz, 2013). Given the data showing the ability of sub-toxic doses of NPs to initiate cellular stress responses, e.g., oxidative stress (Tang et al., 2010; Winnik and Maysinger, 2013), cytokine and exosome release and other intercellular signaling events (Andersson-Willman et al., 2012; Beloribi et al., 2012; Demento et al., 2009; Ristorcelli et al., 2009; Zhu et al., 2012a; Zhu et al., 2012b), there are a number of potentially fruitful, albeit challenging directions for future research into biological mechanisms for NP-induced adaptive and hormetic responses (Demirovic and Rattan, 2013).

UNIQUE FEATURES OF NANOPARTICLES

Nonlinearity from Nanoparticle Properties: Beyond Hormetic Dose-Response Relationships

With nanoparticles, the nonlinearity of responses by cells and organisms may involve even more complexity than with bulk form materials. In contrast with conventional bulk forms of drugs, chemicals, herbs, and other materials, nanoscale forms vary in their effects as a function of not only the dose size, but also seemingly minor variations in their individual particle or aggregate sizes, shapes, and surface charges. Trace “contaminants,” “dopants,” and coatings on the surfaces of nanoparticles can also markedly change their properties, effects and level of toxicity at a given size (Isoda et al., 2011; Kaur and Tikoo, 2012; Kumar et al., 2012; Rowe et al., 2013; Sun et al., 2012; Sur et al., 2012; Van Hoecke et al., 2008; Wang et al., 2012a). The environmental medium in which the NPs interact also modify their toxic or beneficial potential (Kaur and Tikoo, 2012; Mudunkotuwa and Grassian, 2011; Zhang et al., 2012; Zhu et al., 2006).

More highly charged surfaces often lead to greater NP toxicity (Truong et al., 2013; Winnik and Maysinger, 2013). As a result, nanoparticles can evoke nonlinear response patterns from not only hormetic low dose-stimulatory response relationships, but also their inherent physico-chemical properties. That is, a given dose of NPs from the “same” source material can elicit lethal effects for one size nanoparticle, whereas the same dose at another size does not (Browning et al., 2009; Lee et al., 2012b).

In experimental cancer studies, certain sources of nanoparticles and certain sizes of those NPs are more toxic to cancer cells in vitro than to normal cells, e.g., calcium phosphate NPs (Shi et al., 2010b). Enhanced intracellular access in “leaky” blood vessels supporting cancer cells, the inherently reactive surface properties of the NPs inside the cells, and different endogenous biological mechanisms may contribute to the differential cell type toxicity. Size-dependent responses and cell-specific interactions are a widespread phenomenon for NPs (Harhaji et al., 2007; Jiang et al., 2008; Kim et al., 2012; Lankoff et al., 2012).

In the real world environment, NP exposures encompass a wide range of particle sizes and shapes. Some NPs are crudely formed from uncontrolled environmental events that yield, irregular sizes, shapes and properties. Early laboratory methods for making nanoparticles involved prolonged grinding and milling procedures from bulk source materials (top-down methods), which make NPs with many structural irregularities and defects (DeCastro and Mitchell, 2002). Contemporary manufactured nanoparticles necessarily attain more consistent and defect-free shapes and sizes with more precise technological procedures like photo-lithography or bottom-up template synthesis methods (Ju-Nam and Lead, 2008).

In the manufacturing realm, nanotechnologists are also now using plants and other more natural biological agents to biosynthesize “green” silver and gold nanoparticles (Daisy and Saipriya, 2012; Das et al., 2013; Hudecova et al., 2012; Snitka et al., 2012; Suriyakalaa et al., 2012). Biologically synthesized silver and gold NPs have the advantage that the residual amounts of the plant extract adsorb onto the final NP surface and can enhance therapeutic effects while reducing toxicity (Tripathi et al., 2009; Umashankari et al., 2012). Some investigators include plant extracts, phytochemicals and antioxidants in their manufacturing methods to change surface properties and thereby reduce the cellular toxicity potential of certain metal NPs, e.g., silver NPs (Du et al., 2012; Hudecova et al., 2012; Lee et al., 2012a; Mittal et al., 2013; Osborne et al., 2012; Park et al., 2012; Suriyakalaa et al., 2012; Tournebize et al., 2012).

For more general sustainable NP manufacturing, natural plant materials such as English ivy, certain native plants from India, the traditional Chinese herb Cuscuta chinensis, glycyrrhizic acid from radix glycyrrhizae, guar gum, and rice husk also can also release their own organic nanoparticles of various sizes under appropriate conditions (Barve and Chaughule, 2013; Burris et al., 2012; Im et al., 2011; Lenaghan et al., 2013; Salavati-Niasari et al., 2012; Soumya et al., 2010; Wang et al., 2013; Yen et al., 2008). Beyond plant sources, a combination of ball-milling and ultrasound can reduce other organic material sources such as waste eggshells into calcium carbonate nanoparticles (Hassan et al., 2013).

A rationale has been that all of the reagents used in making NPs will adsorb onto the large charged surface area to one degree or another and serve to “dope” or coat and thus modify the primary silver, gold, or silicon NP. Different solvents at different concentrations, for example, result in NPs of the “same” material with different characteristics and sizes (Abbasi and Morsali, 2012; Cao and Wang, 2011; Rao et al., 2005; Yang et al., 2011; Yoo et al., 2006). As a result, the adsorbed materials can change the surface charge and properties of the NPs and thereby, their biological, therapeutic or toxic potential (Lu et al., 2011; Sur et al., 2010). The use of nontoxic or less toxic natural source reagents and materials could reduce toxic waste from NP manufacturing and potentially improve safety of nanomedicine products.

Studies on manufacturing also highlight the need for scrutiny of sample preparation and analytic methods in NP studies (Chikramane et al., 2012). It is important to keep in mind that the precise laboratory conditions in which researchers examine effects of a nanoparticle preparation may influence the findings. In addition to any added solvents and reagents, basic manufacturing parameters such as intensity, duration, and the timing and extent of sonication will affect dispersion of nanoparticles that otherwise aggregate into larger particles with aging (Abbasi and Morsali, 2012; Murdock et al., 2008; Ruan and Jacobi, 2012; Song et al., 2012; Tang et al., 2011). Variations in temperature and pH will also modify the properties of the nanoparticle samples in solution (Abbasi and Morsali, 2012; Rao et al., 2005). Interactions with serum albumin lead to differential agglomeration and sizing of nanostructures during biological experiments (Song et al., 2012; Tantra et al., 2010).

Even making reliable NP concentrations for research purposes is potentially confounded by variations in additional nanostructures that might get into solution from sonication or vortexing agitation of the materials in liquid within different glassware or polymer containers (Betts et al., 2013; Ives et al., 2010; Liu et al., 2012). Taken together, the data indicate the possibility of meaningful interactions between dose size, particle size, sample preparation and testing parameters, and state of the cells or organism at the time of administration in the expression of specific effects.

Quantum Properties of Nanoparticles

Smaller NP sizes also introduce quantum mechanical considerations into the problem for trying to evaluate nonlinear dose-response relationships in a conventional cause-effect medical model (Berec, 2012; Gupta and Wiggers, 2011; Roduner, 2006; Yao and Hughes, 2009). For example, in nano-optics and nano-electronics, the smallest NPs (quantum dots) exhibit the ability to manifest macro quantum entanglement (Berec, 2012; Yao and Hughes, 2009), quantum coherence (Chudnovsky and Friedman, 2000; Hatef et al., 2012), and quantum confinement (Gupta and Wiggers, 2011; Hannah et al., 2012; Kleps et al., 2010) phenomena. Some nanotechnologists take advantage of quantum confinement, for instance, to generate tunable quantum dot NPs with specific optical properties (Biju et al., 2010; Kang et al., 2011; Luther et al., 2011; Troia et al., 2009).

Few medical researchers consider the implications of quantum effects of NPs on biological function (Stovbun et al., 2012). However, some investigators are using the ability of quantum confinement of electrons by different sizes of small NPs (quantum dots, with their atom-like properties) to yield different wavelength colors inside cells for specialized diagnostic imaging methods (Browning et al., 2009; Huang et al., 2012; Lee et al., 2012b; McGuinness et al., 2011; Shalchian et al., 2005; Wang and Chen, 2011). Scientists working at the nanoscale point out the fact that biological processes occur at the nanoscale and sub-nanoscale level. Lloyd recently noted, for instance: “Nature is the great nano-technologist. The chemical machinery that powers biological systems consists of complicated molecules structured at the nanoscale and sub-nanoscale. At these small scales, the dynamics of the chemical machinery is governed by the laws of quantum mechanics” (Lloyd, 2011).

The literature contains only a few papers on the role of quantum physics in biological systems (Davies, 2004). Given limited evidence of the quantum mechanical properties of nanoparticles and their possible role in biological effects of NPs, much research lies ahead to understand the full potential effects of nanoparticles on living organisms. Nonetheless, at least some smaller sized NPs may act within the worlds of both conventional physics and quantum mechanical phenomena, making characterization of their dose-response relationships and mechanisms even more difficult to determine in a reproducible manner.

Still, it is important to realize that the biological effects of nanoparticles may change the scientific rules by which medical studies of nanoparticles are done. Clinical research on NPs could differ in design and even reliability from those for bulk forms of materials. The atom-like properties of very small nanoparticles may force quantum physics into the discussion of their therapeutic and toxicological effects in biology and medicine.

Interactions of NPs with the Organism as a Complex Adaptive System or Network

In the laboratory, technological advances now permit following the random walk of single nanoparticles through an individual organism, revealing the limitations to using averaged or ensemble data for evaluating specific nanoparticle effects (Browning et al., 2009; Lee et al., 2012b). The latter issue of individual variability in NPs and individual differences in responses of each organism may hamper efforts to rely on the proposed average magnitude and response distributions for assessing hormesis from nanoparticles (Nascarella and Calabrese, 2012). Awareness of these factors, however, can reduce the risk of overly broad assumptions or generalizations about the effects of NPs in living systems, including relative to hormesis.

So far, this paper has alluded to the complex nonlinear dynamics and network organization of the organism as another factor in modifying the nature, magnitude and direction of nanoparticle effects (Sugarman et al., 2013). What are the implications of considering the interaction of the nanostructured material with an individual organism? In his text, Introduction to Nanoscience, Lindsay (Lindsay, 2010) commented: “Nanoscience is where atomic physics converges with the physics and chemistry of complex systems.”

Current thinking suggests that the adaptive response nature of hormesis is a manifestation of biological plasticity (Calabrese and Mattson, 2011). As a result, the dose-response observations reflect emergent interactions of a given mild stressor or low dose agent with a specific organism in a particular dynamic state, modified by genetics and past experiences. Biological metaplasticity, or the plasticity of plasticity can reverse directionality of responses as a function of past adaptations around a set point compatible with maintaining homeostatic balance (Abraham, 2008; Antelman and Caggiula, 1996). Moreover, for in vivo studies, NPs may yield very different findings from in vitro experiments (Clift et al., 2011; Lu et al., 2011). Using intact organisms may ultimately be necessary to understand when and how NPs might cause hormesis and other nonlinear responses, e.g., stochastic resonance (Chen et al., 2012; McDonnell and Abbott, 2009).

Complete organisms and intact cells are each complex adaptive systems (CAS) at different levels of scale. CASs are interconnected, interactive and interdependent networks of self-organized components. The specialized components in turn generate emergent properties at the higher levels of organization not seen in the individual parts (Pincus and Metten, 2010). Furthermore, a CAS can change behaviors over time at different time scales, with a range between order and chaos that adapts nonlinearly to changes in the environment.

The result observed can vary, revealing degrees of resilience from the capacity for adjusting intrinsic flexibility and stability in the behaviors of the complex system. The dynamic self-organized “goal” for a CAS is to optimize the organism or cell's fitness within a given environment to the extent possible within the current state and meta-flexibility of the system (Pincus and Metten, 2010). The nature, magnitude, and direction of the change can be difficult to predict in a CAS, especially at critical points of dynamical instability (Hollenstein, 2007; Malarczyk et al., 2011; Sugarman et al., 2013). In addition, Figure 3 illustrates some time-dependent variables in a living CAS, e.g., developmental state of the recipient organism and the frequency of repeated exposures that can influence the adaptive changes and even the direction of the observed responses, apart from the dose itself.

FIGURE 3A.

Time-Dependent Interactions of Host and Environment that Can Affect the Initiation and Direction of Responses in a Nonlinear Dynamical System such as a Living Organism. Developmental phase transition in an adolescent human being can destabilize system dynamics and lead to subsequent self-reorganization of interpersonal interaction dynamics over time. Reprinted with permission (Hollenstein, 2007).

FIGURE 3B.

Overly frequent repetitions of a low dose environmental stressor (e.g., experimental cocaine pretreatments in an animal during a sensitization protocol study of brain striatal dopamine efflux evoked by eliciting dose of cross-sensitized amphetamine) leads to reversal of direction in observed responses over consecutive repetitive exposures. Reprinted with permission (Antelman et al., 1997).

Some researchers in nonlinear dynamical systems (NDS) propose that disease and aging reflect losses of complexity in the dynamics of the organism (Costa, 2002, 2007; Costa et al., 2002; Fredrickson and Losada, 2005; Goldberger et al., 2002; Losada, 1999; Losada and Heaphy, 2004). With regard to high doses of nanoparticles and other small particles from air pollution, many believe that such toxic level exposures promote disease, as reflected in a loss of complexity in physiological measures such as heart rate variability (Shannahan et al., 2012).

However, studies on the effects of lower, subtoxic NP doses reveal individual variability in the effects of the agent on different organisms receiving the “same” exposure. Stressing a CAS and observing how it responds to the stressor in spatially and temporally remote areas of function can reveal the larger capacity for resilience of the individual organism (Bar-Yam, 1997; Bar-Yam and Epstein, 2004). Cause-effect relationships in CAS tend to be indirect rather than direct. Overwhelming intensities of stress can completely disrupt a complex biochemical network, for instance, whereas lesser levels of stress may simply induce a self-reorganization of function to cope with the effects (Mihalik and Csermely, 2011; Szalay et al., 2007)(Figure 4).

FIGURE 4.

Effects of Different Levels of Stress on Functional Network Organization of a Complex Adaptive System. Reprinted with permission (Szalay et al., 2007). Note: Solid and dotted lines represent strong and weak (high and low affinity) links, respectively.

For instance, with silver NP exposures at sub-lethal doses, some developing zebrafish organisms remain healthy whereas others develop deformities (Lee et al., 2012b). Those with the deformities show an NP size-dependent effect, with larger numbers of larger versus smaller size silver NPs accumulating inside the surviving deformed versus healthy individuals, at the same given molar concentration. Such data support the likely interactions of subtoxic nanoparticle doses and sizes with the state of the organisms at the time of exposure. The dynamical state of the individual CAS here would translate into the variable ability of blood vessel integrity and cell membranes either to allow or to block entry of the damaging larger-sized nanoparticles inside the cells, e.g., (Shi et al., 2010b).

In the therapeutic realm, harnessing low doses of certain sized nanoparticles as hormetic stimuli may be useful. It is instructive to look at research on using low level discrete, well-timed stimuli to mobilize widespread changes in function of the overall organism. For example, adding a low level, subsensory noise applied to the feet of elderly individuals can improve the complexity of sway fluctuations in their postural balance (Costa, 2007). Adding noise in the latter case enhances the ability to detect otherwise age-weakened sensory signals within the organism. On the other hand, applying discrete pulsed electrical stimuli with precise magnitude and timing for the individual's diseased state (i.e., which is emergent biological “noise”) can disrupt and normalize cardiac arrhythmias or experimental epileptic seizure activity in the brain (Coffey, 1998; Garfinkel et al., 1992; Schiff et al., 1994).

One underlying theory for the clinical benefits of introducing a small or weak signal within a larger endogenous noise in a CAS is stochastic resonance (SR) (Casado-Pascual et al., 2003; Czaplicka et al., 2013; Kelty-Stephen and Dixon, 2013; Korn and Faure, 2003; Krawiecki et al., 2000; Magalhaes and Kohn, 2011; McDonnell and Abbott, 2009; Pinamonti et al., 2012; Torres and Ruiz, 1996). SR is a phenomenon which involves the ability of a small signal to exert noise-enhanced amplified effects when given in the background of the much larger noise to a nonlinear complex system (Figure 5) (McDonnell and Abbott, 2009).

FIGURE 5.

Nature of Stochastic Resonance (SR) as a Model Nonlinear Process for Noise-Enhanced Small Signals. Typical SR Curve of Output Performance versus Input Noise Magnitude for Complex Systems Capable of Stochastic Resonance. Reprinted under the Creative Commons License with Attribution (McDonnell and Abbott, 2009).

Certain nanoparticles, e.g., carbon nanotube transistors, can evoke this type of noise-amplified response to a weak signal in a non-living complex system (Lee et al., 2006). In biological systems, previous studies have demonstrated stochastic resonance in sensory systems. SR is involved, for example, in crayfish detection of incident pressure waves from predators as well as in human visual perception and balance control (Moss et al., 2004). To further explore SR-related phenomena, Lee et al (2010) showed coherence resonance or self-synchronization at an optimal noise level, in transport of single ions through the interior of a 500 micrometer long carbon nanotube. The latter observations involved increases in throughput of the nanopore by a factor of 100 (Lee et al., 2010).

SR is a testable hypothesis as one way in which a pulsed dose of a salient, low dose agent or nanoparticle might initiate the cascades of amplified biological signaling reported in hormesis (Calabrese, 2013). The “noise” in an adaptive living system might be a pattern of dysfunctions manifesting as a disease, toxicity, or aging (Soti and Csermely, 2007). Then the therapeutic strategy could be either (a) to add noise to enhance sensory detection capacity in an aging individual (Costa et al., 2007) or (b) to introduce a salient mild hormetic signal into the pre-existing systemic noise of disease to trigger a reversal of direction toward health (Stark, 2012; Torres and Ruiz, 1996; Van Wijk and Wiegant, 2011; Yu et al., 2013).

SR may play a role in the aging process and in anti-aging interventions. Soti and Csermely (2007) have proposed that aging leads to increased noise in the functional cellular biochemical networks. The noise grows via cumulative damage to weak biochemical network links involving chaperone proteins such as heat shock proteins. Both aging and disease can induce a loss of complexity in the nonlinear dynamics of a complex adaptive system across levels of organizational scale, including cell systems, physiological systems, and whole organisms (Costa, 2007; Costa et al., 2005; Fredrickson and Losada, 2005; Goldberger, 1996; Goldberger et al., 2002; Hollenstein, 2007; Pincus and Metten, 2010; Soti and Csermely, 2003, 2007).

However, well-timed mild hormetic stressors from certain nanoparticles in low doses and certain particle sizes could serve as one type of small salient SR signal embedded in the larger noise to trigger beneficial recovery of complexity in the system (Stark, 2012; Sugarman et al., 2013). Modulation of heat shock proteins offers a potential biological mechanism (Soti and Csermely, 2006) by which to reverse age- or disease-related loss of complexity in the adaptive networks of cells. In hormesis research, one intervention strategy involves postconditioning hormesis to elicit therapeutic effects in heat shock protein activation patterns from mild (low dose) hormetic environmental stimuli (Van Wijk and Wiegant, 2010; Wiegant et al., 2011). Previous studies have already shown the capacity of various nanoparticles at toxic doses to modulate heat shock protein activation patterns (Farmen et al., 2012; Foldbjerg et al., 2012; Lim et al., 2012; Richert et al., 2012; Siddiqi et al., 2012; Zhao et al., 2012).

It is not always necessary to use low doses of the same specific stressor that may have caused deterioration. In the adaptive stress response networks, the phenomenon of cross-adaptation or cross-resistance (Hale, 1969; Milisav et al., 2012) could permit selection of a heterologous, cross-adapted stressor to serve as the hormetic stimulus. Newer evidence suggests that low doses of certain salient cross-adapted nanoparticles could act as such postconditioned hormetic stressors (Bell and Schwartz, 2013). It may also be possible, as Vaiserman has proposed, to use intermittent mild hormetic stressors to initiate preconditioned hormesis and adaptive changes for preventive purposes (Vaiserman, 2010, 2011). Nonetheless, identifying the optimal conditions for beneficial shaping of health- and longevity-promoting exposures remains a challenge (Pickering et al., 2013).

For low doses of small nanoparticles to act via stochastic resonance, e.g., in hormesis, they would need to take advantage of endogenous amplification processes possible within the individual as a nonlinear complex adaptive system (McDonnell and Abbott, 2009). Notably, the NPs would need to arrive as a discrete properly-timed, pulsed low intensity signal rather than at continuous dosing levels (Antelman et al., 2000; Casado-Pascual et al., 2003; Kelty-Stephen and Dixon, 2013). While speculative, the concept of stochastic resonance in complex adaptive systems could add a new layer of discovery to advance our understanding of the circumstances in which the effects of hormesis might be utilized for prevention or treatment of disease.

CONCLUSIONS

In conclusion, for the therapeutic application of hormesis with NPs (Iavicoli et al., 2010; Nascarella and Calabrese, 2012), additional considerations beyond traditional dose explanations likely come into play to understand nonlinear responses. Numerous interacting factors related to nanoparticle size, shape, and surface charge, in addition to the material composition and low dose, determine the net effects of particular nanoparticles in a given study. The NPs then interact with individual differences in the dynamical state of the cells and organisms as complex adaptive systems to generate emergent nonlinear effects.

The time-dependent, multifactorial and individualized nature of adaptive phenomena raises significant questions about the most appropriate experimental designs on NP hormesis. Careful characterization of nanoparticles used in a given study and the pre-treatment dynamical state of the individual recipient organisms or cells may lessen the risk of generating confusing and even irreproducible findings in this field (Chang and Vikesland, 2013; Vijayaraghavan and Nalini, 2010; Xia et al., 2009). Even relying on averaged versus individualized data may be misleading (Browning et al., 2009; Huang et al., 2012; Lee et al., 2012b).

Implications of the available literature for future studies on NPs and hormesis include:

Because of enhanced biological potencies of NPs, it is necessary to look for significant down-shifting to the left along the x-axis for dose levels below the no-observed-adverse-effect-level (NOAEL) where hormesis is more likely to occur. That is, in some cases, hormetic doses of some NPs may sometimes occur at levels below 1 nanomolar concentration. However, since NP size and surface chemistries can vary in a given environment, the cut-off levels for their direct and indirect therapeutic and/or toxic effects may also vary accordingly.

Because of the potential interactions of small particle size and low dose with the state of the recipient complex adaptive system, developing multifactorial models for biological plasticity mechanisms of hormesis may be particularly important with nanoscale materials.

For therapeutic applications of hormesis using NPs, dosing regimens may need to involve discrete pulsed rather than continuous administration of the low doses of specific sized NPs in order to take advantage of biological signaling and nonlinear stochastic resonance. Timing of NPs can affect the nature and direction of the response (Hossu et al., 2010; Jonasson et al., 2013; Vesterdal et al., 2010). The amplified effects of small pulsed signals in the context of a larger noisy signal can produce large magnitude, clinically significant change in an individual as a complex adaptive system (Costa, 2007; Ichiki and Tadokoro, 2013; McDonnell and Abbott, 2009; Pinamonti et al., 2012; Soti and Csermely, 2007).

The past decade has seen an explosion of research and discovery in nanoscience, nanotechnology, and nanomedicine. The potential of interacting therapeutic nanoparticles with hormetic dose treatment strategies is largely unexplored. Tools from systems biology (Abu-Asab et al., 2011), network analysis (Farkas et al., 2011) and nonlinear dynamical systems (Pincus and Metten, 2010) may facilitate this direction for future research. The evidence supports the importance of exploratory and hypothesis-driven studies in this area.

References

Abbasi

and Morsali

. 2012. Influence of solvents on the morphological properties of AgBr nanostructures prepared using ultrasound irradiation. Ultrason Sonochem 19:540–545

Abraham

. 2008. Metaplasticity: tuning synapses and networks for plasticity. Nat Rev Neurosci 9:387

Abu-Asab

Chaouchi

Alesci

Galli

Laassri

Cheema

Atouf

VanMeter

, and Amri

. 2011. Biomarkers in the age of omics: time for a systems biology approach. OMICS. 2011 Mar;15(3):105–12. Epub 2011 Feb 14.

Ahmad

and Khuller

. 2008. Alginate-based sustained release drug delivery systems for tuberculosis. Expert Opin Drug Deliv 5:1323–1334

Ahmad

Pandey

Sharma

, and Khuller

. 2006. Alginate nanoparticles as antituberculosis drug carriers: formulation development, pharmacokinetics and therapeutic potential. Indian J Chest Dis Allied Sci 48:171–176

Ahn

Barrett

Raja

Jozefik

, and Spaho

. 2013. Nano-Encapsulation of Arsenic Trioxide Enhances Efficacy against Murine Lymphoma Model while Minimizing Its Impact on Ovarian Reserve In Vitro and In Vivo. PLoS ONE 8:e58491

Al-Sadoon

Abdel-Maksoud

Rabah

, and Badr

. 2012. Induction of Apoptosis and Growth Arrest in Human Breast Carcinoma Cells by a Snake (Walterinnesia aegyptia) Venom Combined With Silica Nanoparticles: Crosstalk Between Bcl2 and Caspase 3. Cell Physiol Biochem 30:653–665

Andersson-Willman

Gehrmann

Cansu

Buerki-Thurnherr

Krug

Gabrielsson

, and Scheynius

. 2012. Effects of subtoxic concentrations of TiO(2) and ZnO nanoparticles on human lymphocytes, dendritic cells and exosome production. Toxicol Appl Pharmacol 264:94–103

Antelman

and Caggiula

. 1996. Oscillation follows drug sensitization: implications. Critical Reviews in Neurobiology. 10:101–117

10.

Antelman

Caggiula

Gershon

Edwards

Austin

Kiss

, and Kocan

. 1997. Stressor-induced oscillation. A possible model of the bidirectional symptoms in PTSD. Annals of the New York Academy of Sciences. 821:296–304

11.

Antelman

Caggiula

Knopf

Kocan

, and Edwards

. 1992. Amphetamine or haloperidol 2 weeks earlier antagonized the plasma corticosterone response to amphetamine; evidence for the stressful/foreign nature of drugs. Psychopharmacology. 107:331–336

12.

Antelman

Eichler

Black

, and Kocan

. 1980. Interchangeability of stress and amphetamine in sensitization. Science. 207:329–331

13.

Antelman

Levine

, and Gershon

. 2000. Time-dependent sensitization: the odyssey of a scientific heresy from the laboratory to the door of the clinic. Molecular Psychiatry. 5:350–356

14.

Armstead

and Li

. 2011. Nanomedicine as an emerging approach against intracellular pathogens. Int J Nanomedicine 6:3281–3293

15.

Avena

and Hoebel

. 2003. Amphetamine-sensitized rats show sugar-induced hyperactivity (cross-sensitization) and sugar hyperphagia. Pharmacol Biochem Behav 74:635–639

16.

Bagwe

Hilliard

, and Tan

. 2006. Surface modification of silica nanoparticles to reduce aggregation and nonspecific binding. Langmuir 22:4357–4362

17.

Banti

Loreti

Novi

Santaniello

Alpi

, and Perata

. 2008. Heat acclimation and cross-tolerance against anoxia in Arabidopsis. Plant Cell Environ 31:1029–1037

18.

Bar-Yam

. 1997. Dynamics of Complex Systems. Perseus Books, Reading, MA

19.

Bar-Yam

and Epstein

. 2004. Response of complex networks to stimuli. Proceedings of the National Academy of Sciences of the United States of America 101:4341–4345

20.

Barua

Konwarh

Bhattacharya

Das

Devi

Maiti

Mandal

, and Karak

. 2013. Nonhazardous anticancerous and antibacterial colloidal ‘green’ silver nanoparticles. Colloids Surf B Biointerfaces 105:37–42

21.

Barve

and Chaughule

. 2013. Size-dependent in vivo/in vitro results of homoeopathic herbal extracts. Journal of Nanostructure in Chemistry 3:18

22.

Bel Haaj

Magnin

Petrier

, and Boufi

. 2013. Starch nanoparticles formation via high power ultrasonication. Carbohydrate polymers 92:1625–1632

23.

Bell

and Schwartz

. 2013. Adaptive network nanomedicine: an integrated model for homeopathic medicine. Frontiers in Bioscience (Scholar Ed.) 5:685–708

24.

Beloribi

Ristorcelli

Breuzard

Silvy

Bertrand-Michel

Beraud

Verine

, and Lombardo

. 2012. Exosomal Lipids Impact Notch Signaling and Induce Death of Human Pancreatic Tumoral SOJ-6 Cells. PLoS One 7:e47480

25.

Berec

. 2012. Quantum entanglement and spin control in silicon nanocrystal. PLoS One 7:e45254

26.

Bershteyn

Hanson

Crespo

Moon

Suh

, and Irvine

. 2012. Robust IgG responses to nanograms of antigen using a biomimetic lipid-coated particle vaccine. J Control Release 157:354–365

27.

Betts

Johnson

Rygiewicz

King

, and Andersen

. 2013. Potential for metal contamination by direct sonication of nanoparticle suspensions. Environ Toxicol Chem 32:889–893

28.

Biju

Itoh

, and Ishikawa

. 2010. Delivering quantum dots to cells: bioconjugated quantum dots for targeted and nonspecific extracellular and intracellular imaging. Chem Soc Rev 39:3031–3056

29.

Bourdineaud

Rossignol

, and Brethes

. 2013. Zebrafish: a model animal for analyzing the impact of environmental pollutants on muscle and brain mitochondrial bioenergetics. Int J Biochem Cell Biol 45:16–22

30.

Browning

Lee

Huang

Nallathamby

Lowman

, and Xu

. 2009. Random walk of single gold nanoparticles in zebrafish embryos leading to stochastic toxic effects on embryonic developments. Nanoscale 1:138–152

31.

Burris

Lenaghan

Zhang

, and Stewart

. 2012. Nanoparticle biofabrication using English ivy (Hedera helix). J Nanobiotechnology 10:41

32.

Buzea

Pacheco II , and Robbie

. 2007. Nanomaterials and nanoparticles: sources and toxicity. Biointerphases 2:MR17–71

33.

Calabrese

. 2013. Hormetic mechanisms. Critical Reviews in Toxicology 43:580–606

34.

Calabrese

Bachmann

Bailer

Bolger

Borak

Cai

Cedergreen

Cherian

Chiueh

Clarkson

Cook

Diamond

Doolittle

Dorato

Duke

Feinendegen

Gardner

Hart

Hastings

Hayes

Hoffmann

Ives

Jaworowski

Johnson

Jonas

Kaminski

Keller

Klaunig

Knudsen

Kozumbo

Lettieri

Liu

Maisseu

Maynard

Masoro

McClellan

Mehendale

Mothersill

Newlin

Nigg

Oehme

Phalen

Philbert

Rattan

Riviere

Rodricks

Sapolsky

Scott

Seymour

Sinclair

Smith-Sonneborn

Snow

Spear

Stevenson

Thomas

Tubiana

Williams

, and Mattson

. 2007. Biological stress response terminology: Integrating the concepts of adaptive response and preconditioning stress within a hormetic dose-response framework. Toxicol Appl Pharmacol 222:122–128

35.

Calabrese

and Mattson

. 2011. Hormesis provides a generalized quantitative estimate of biological plasticity. J Cell Commun Signal 5:25–38

36.

Cao

and Wang

. 2011. Nanostructures and Nanomaterials: Synthesis, Properties, and Applications 2nd Edition. World Scientific, New Jersey

37.

Casado-Pascual

Gomez-Ordonez

Morillo

, and Hanggi

. 2003. Subthreshold stochastic resonance: rectangular signals can cause anomalous large gains. Phys Rev E Stat Nonlin Soft Matter Phys 68:061104

38.

Chang

and Vikesland

. 2013. Uncontrolled Variability in the Extinction Spectra of C60 Nanoparticle Suspensions. Langmuir 29:9685–9693

39.

Chaowanachan

Krogstad

Ball

, and Woodrow

. 2013. Drug Synergy of Tenofovir and Nanoparticle-Based Antiretrovirals for HIV Prophylaxis. PLoS One 8:e61416

40.

Chen

Powell

Mortimer

, and Ke

. 2012. Adaptive Interactions between Zinc Oxide Nanoparticles and Chlorella sp. Environ Sci Technol 46:12178–12185

41.

Chikramane

Kalita

Suresh

Kane

, and Bellare

. 2012. Why Extreme Dilutions Reach Non-zero Asymptotes: A Nanoparticulate Hypothesis Based on Froth Flotation. Langmuir 28:15864–15875

42.

Cho

Choi

Noh

Jeon

Jung

, and Nam

. 2011. Dependence of milling time on electrochemical properties of nano Si electrodes prepared by ball-milling. J Nanosci Nanotechnol 11:6262–6265

43.

Chu

Feng

, and Li

. 2012. Hydroxyapatite nanoparticles inhibit the growth of human glioma cells in vitro and in vivo. Int J Nanomedicine 7:3659–3666

44.

Chudnovsky

and Friedman

. 2000. Macroscopic Quantum Coherence in a Magnetic Nanoparticle Above the Surface of a Superconductor. Physical Review Letters 85:5206–5209

45.

Chun

Bisht

Chenna

Pramanik

Yoshida

Hong

de Wilde

Zhang

Huso

Zhao

Rudek

Stearns

Maitra

, and Sukumar

. 2012. Intraductal administration of a polymeric nanoparticle formulation of curcumin (NanoCurc) significantly attenuates incidence of mammary tumors in a rodent chemical carcinogenesis model: Implications for breast cancer chemoprevention in at-risk populations. Carcinogenesis 33:2242–2249

46.

Clark

Dang

, and Veinot

. 2010. Exploration of organic acid chain length on water-soluble silicon quantum dot surfaces. Langmuir 26:15657–15664

47.

Clift

Gehr

, and Rothen-Rutishauser

. 2011. Nanotoxicology: a perspective and discussion of whether or not in vitro testing is a valid alternative. Arch Toxicol 85:723–731

48.

Coffey

. 1998. Self-organization, complexity, and chaos: the new biology for medicine. Nature Medicine. 4:882–885

49.

Cole

Yang

, and David

. 2011. Cancer theranostics: the rise of targeted magnetic nanoparticles. Trends Biotechnol 29:323–332

50.

Costa

Goldberger

, and Peng

. 2002. Multiscale entropy to distinguish physiologic and synthetic RR time series. Comput Cardiol 29:137–140

51.

Costa

Goldberger

, and Peng

. 2005. Multiscale entropy analysis of biological signals. Physical Review E 71:1–18

52.

Costa

Goldberger

, and Peng

. 2002. Multiscale entropy analysis of complex physiologic time series. Phys Rev Lett 89:068102:068101–068104

53.

Costa

Priplata

Lipsitz

Huang

Goldberger

, and Peng

. 2007. Noise and poise: Enhancement of postural complexity in the elderly with a stochastic-resonance-based therapy. Europhys Lett. 77:68008

54.

Cumbo

Lorber

Corvini

Meier

, and Shahgaldian

. 2013. A synthetic nanomaterial for virus recognition produced by surface imprinting. Nat Commun 4:1503

55.

Czaplicka

Holyst

, and Sloot

. 2013. Noise enhances information transfer in hierarchical networks. Sci Rep 3:1223

56.

Daisy

and Saipriya

. 2012. Biochemical analysis of Cassia fistula aqueous extract and phytochemically synthesized gold nanoparticles as hypoglycemic treatment for diabetes mellitus. Int J Nanomedicine 7:1189–1202

57.

Dar

Ingle

, and Rai

. 2013. Enhanced antimicrobial activity of silver nanoparticles synthesized by Cryphonectria sp. evaluated singly and in combination with antibiotics. Nanomedicine 9:105–110

58.

Das

Samadder

Bhattacharyya

Das

, and Khuda-Bukhsh

. 2013. Biosynthesized silver nanoparticles by ethanolic extracts of Phytolacca decandra, Gelsemium sempervirens, Hydrastis canadensis and Thuja occidentalis induce differential cytotoxicity through G2/M arrest in A375 cells. Colloids and Surfaces B: Biointerfaces 101:325–336

59.

Davies

. 2004. Does quantum mechanics play a non-trivial role in life? Biosystems 78:69–79

60.

DeCastro

and Mitchell

. 2002. Nanoparticles from mechanical attrition, in: Baraton

(Ed.), Synthesis, Functionalization, and Surface Treatment of Nanoparticles. American Scientific Publisher, Valencia, CA, pp. 1–15

61.

Demento

Eisenbarth

Foellmer

Platt

Caplan

Mark Saltzman

Mellman

Ledizet

Fikrig

Flavell

, and Fahmy

. 2009. Inflammasome-activating nanoparticles as modular systems for optimizing vaccine efficacy. Vaccine 27:3013–3021

62.

Demirovic

and Rattan

. 2013. Establishing cellular stress response profiles as biomarkers of homeodynamics, health and hormesis. Exp Gerontol 48:94–98

63.

Diwan

Elamanchili

Cao

, and Samuel

. 2004. Dose sparing of CpG oligodeoxynucleotide vaccine adjuvants by nanoparticle delivery. Curr Drug Deliv 1:405–412

64.

Miao

Jiang

Jia

Tian

Shen

, and Liu

. 2013. An effective strategy for the synthesis of biocompatible gold nanoparticles using danshensu antioxidant: prevention of cytotoxicity via attenuation of free radical formation. Nanotoxicology 7:94–300

65.

European Commission on the Environment. 2011. Nanomaterials, Definition of nanomaterials. Available at http://ec.europa.eu/environment/chemicals/nanotech/faq/definition_en.htm

66.

Farkas

Korcsmaros

Kovacs

Mihalik

Palotai

Simko

Szalay

Szalay-Beko

Vellai

Wang

, and Csermely

. 2011. Network-based tools for the identification of novel drug targets. Sci Signal 4:pt3

67.

Farmen

Mikkelsen

Evensen

Einset

Heier

Rosseland

Salbu

Tollefsen

, and Oughton

. 2012. Acute and sub-lethal effects in juvenile Atlantic salmon exposed to low mug/L concentrations of Ag nanoparticles. Aquat Toxicol 108:78–84

68.

Foldbjerg

Irving

Hayashi

Sutherland

Thorsen

Autrup

, and Beer

. 2012. Global gene expression profiling of human lung epithelial cells after exposure to nanosilver. Toxicol Sci

69.

Fredrickson

and Losada

. 2005. Positive affect and the complex dynamics of human flourishing. American Psychologist 60:678–686

70.

Garfinkel

Spano

Ditto

, and Weiss

. 1992. Controlling cardiac chaos. Science. 257:1230–1235

71.

Gautam

Dubey

, and Gupta

. 2013. A facile and green ultrasonic-assisted synthesis of BSA conjugated silver nanoparticles. Colloids Surf B Biointerfaces 102:879–883

72.

Geinguenaud

Souissi

Fagard

Motte

, and Lalatonne

. 2012. Electrostatic assembly of a DNA superparamagnetic nano-tool for simultaneous intracellular delivery and in situ monitoring. Nanomedicine 8:1106–1115

73.

Ghosh

Choudhury

Ghosh

Mandal

Sarkar

Ghosh

Saha

, and Das

. 2012. Nanocapsulated curcumin: oral chemopreventive formulation against diethylnitrosamine induced hepatocellular carcinoma in rat. Chem Biol Interact 195:206–214

74.

Goldberger

. 1996. Non-linear dynamics for clinicians: chaos theory, fractals, and complexity at the bedside. Lancet 347:1312–1314

75.

Goldberger

Peng

, and Lipsitz

. 2002. What is physiologic complexity and how does it change with aging and disease? Neurobiol Aging 23:23–26

76.

Gosnell

. 2005. Sucrose intake enhances behavioral sensitization produced by cocaine. Brain Res 1031:194–201

77.

Gualtieri

Skuland

Iversen

Lag

Schwarze

Bilanicova

Pojana

, and Refsnes

. 2012. Importance of agglomeration state and exposure conditions for uptake and pro-inflammatory responses to amorphous silica nanoparticles in bronchial epithelial cells. Nanotoxicology 6:700–712

78.

Gupta

and Wiggers

. 2011. Freestanding silicon quantum dots: origin of red and blue luminescence. Nanotechnology 22:055707

79.

Hale

. 1969. Cross-adaptation. Environmental Research 2:423–434

80.

Hannah

Yang

Podsiadlo

Chan

Demortiere

Gosztola

Prakapenka

Schatz

Kortshagen

, and Schaller

. 2012. On the origin of photoluminescence in silicon nanocrystals: pressure-dependent structural and optical studies. Nano Lett 12:4200–4205

81.

Harhaji

Isakovic

Raicevic

Markovic

Todorovic-Markovic

Nikolic

Vranjes-Djuric

Markovic

, and Trajkovic

. 2007. Multiple mechanisms underlying the anticancer action of nanocrystalline fullerene. Eur J Pharmacol 568:89–98

82.

Hassan

Rangari

Rana

, and Jeelani

. 2013. Sonochemical effect on size reduction of CaCO3 nanoparticles derived from waste eggshells. Ultrason Sonochem 20:1308–1315

83.

Hatef

Sadeghi

, and Singh

. 2012. Coherent molecular resonances in quantum dot-metallic nanoparticle systems: coherent self-renormalization and structural effects. Nanotechnology 23:205203

84.

Sun

, and Sun

. 2011. Monodisperse magnetic nanoparticles for theranostic applications. Acc Chem Res 44:875–882

85.

and Leong

. 2010. Quantum dot-based theranostics. Nanoscale 2:60–68

86.

Hollenstein

. 2007. State space grids: analyzing dynamics across development. International Journal of Behavioral Development. 31:384–396

87.

Hossu

, and Chen

. 2010. Nonlinear enhancement of spontaneous biophoton emission of sweet potato by silver nanoparticles. J Photochem Photobiol B. 99:44–48

88.

Huang

Browning

, and Xu

. 2012. Far-field photostable optical nanoscopy (PHOTON) for real-time super-resolution single-molecular imaging of signaling pathways of single live cells. Nanoscale 4:2797–2812

89.

Huang

Kang

Qian

Mackey

Chen

Oyelere

El-Sayed

, and El-Sayed

. 2010. Comparative study of photothermolysis of cancer cells with nuclear-targeted or cytoplasm-targeted gold nanospheres: continuous wave or pulsed lasers. J Biomed Opt 15:058002

90.

Hudecova

Kusznierewicz

Runden-Pran

Magdolenova

Hasplova

Rinna

Fjellsbo

Kruszewski

Lankoff

Sandberg

Refsnes

Skuland

Schwarze

Brunborg

Bjoras

Collins

Miadokova

Galova

, and Dusinska

. 2012. Silver nanoparticles induce pre-mutagenic DNA oxidation that can be prevented by phytochemicals from Gentiana asclepiadea. Mutagenesis 27:759–769

91.

Iavicoli

Calabrese

, and Nascarella

. 2010. Exposure to nanoparticles and hormesis. Dose Response 8:501–517

92.

Ichiki

and Tadokoro

. 2013. Relation between optimal nonlinearity and non-Gaussian noise: enhancing a weak signal in a nonlinear system. Phys Rev E Stat Nonlin Soft Matter Phys 87:012124

93.

Wahab

Ameen

Kim

Yang

, and Shin

. 2011. Synthesis and characterization of high-purity silica nanosphere from rice husk. J Nanosci Nanotechnol 11:5934–5938

94.

International Organization for Standardization. 2005. ISO/TC 229 Nanotechnologies, Standardization in the field of nanotechnologies. Available at http://www.iso.org/iso/iso_technical_committee?commid=381983

95.

Isoda

Hasezaki

Kondoh

Tsutsumi

, and Yagi

. 2011. Effect of surface charge on nano-sized silica particles-induced liver injury. Pharmazie 66:278–281

96.

Ives

Moffett

Arun

Lam

Todorov

Brothers

Anick

Centeno

Namboodiri

, and Jonas

. 2010. Enzyme stabilization by glass-derived silicates in glass-exposed aqueous solutions. Homeopathy 99:15–24

97.

Jena

Mohanty

Mallick

Jacob

, and Sonawane

. 2012. Toxicity and antibacterial assessment of chitosancoated silver nanoparticles on human pathogens and macrophage cells. Int J Nanomedicine 7:1805–1818

98.

Jiang

Kim

Rutka

, and Chan

. 2008. Nanoparticle-mediated cellular response is size-dependent. Nat Nanotechnol 3:145–150

99.

Jonasson

Gustafsson

Koch

, and Bucht

. 2013. Inhalation exposure of nano-scaled titanium dioxide (TiO2) particles alters the inflammatory responses in asthmatic mice. Inhal Toxicol 25:179–191

100.

Joshi

and Muller

. 2009. Lipid nanoparticles for parenteral delivery of actives. Eur J Pharm Biopharm 71:161–172

101.

Ju-Nam

and Lead

. 2008. Manufactured nanoparticles: an overview of their chemistry, interactions and potential environmental implications. Sci Total Environ 400:396–414

102.

Kang

Liu

, and Lee

. 2011. Small-sized silicon nanoparticles: new nanolights and nanocatalysts. Nanoscale 3:777–791

103.

Kaur

and Tikoo

. 2012. Evaluating cell specific cytotoxicity of differentially charged silver nanoparticles. Food Chem Toxicol 51C:1–14

104.

Kelty-Stephen

and Dixon

. 2013. Temporal correlations in postural sway moderate effects of stochastic resonance on postural stability. Hum Mov Sci 32:91–105

105.

Kiel

Grinberg

Perkas

Charmet

Kepner

, and Gedanken

. 2012. Forming nanoparticles of water-soluble ionic molecules and embedding them into polymer and glass substrates. Beilstein J Nanotechnol 3:267–276

106.

Kim

Park

Shin

Gong

, and Kim

. 2012. Size-dependent cellular toxicity of silver nanoparticles. J Biomed Mater Res A 100:1033–1043

107.

Kleps

Ignat

Miu

Craciunoiu

Trif

Simion

Bragaru

, and Dinescu

. 2010. Nanostructured silicon particles for medical applications. J Nanosci Nanotechnol 10:2694–2700

108.

Koning

and Krijger

. 2007. Targeted multifunctional lipid-based nanocarriers for image-guided drug delivery. Anticancer Agents Med Chem 7:425–440

109.

Korn

and Faure

. 2003. Is there chaos in the brain? II. Experimental evidence and related models. [Review] [343 refs]. Comptes Rendus Biologies 326:787–840

110.

Krawiecki

Sukiennicki

, and Kosinski

. 2000. Stochastic resonance and noise-enhanced order with spatiotemporal periodic signal. Phys Rev E Stat Phys Plasmas Fluids Relat Interdiscip Topics 62:7683–7689

111.

Kumar

Kumari

Guleria

, and Yadav

. 2012. Evaluating the toxicity of selected types of nanochemicals. Rev Environ Contam Toxicol 215:39–121

112.

Lagisz

Hector

, and Nakagawa

. 2013. Life extension after heat shock exposure: Assessing meta-analytic evidence for hormesis. Ageing Res Rev 12:653–60

113.

Lanao

Briones

, and Colino

. 2007. Recent advances in delivery systems for anti-HIV1 therapy. J Drug Target 15:21–36

114.

Lankoff

Arabski

Wegierek-Ciuk

Kruszewski

Lisowska

Banasik-Nowak

Rozga-Wijas

Wojewodzka

, and Slomkowski

. 2013. Effect of surface modification of silica nanoparticles on toxicity and cellular uptake by human peripheral blood lymphocytes in vitro. Nanotoxicology 7:235–50

115.

Launay

Besnard

Guinet-Lebreton

, and Savourey

. 2006. Acclimation to intermittent hypobaric hypoxia modifies responses to cold at sea level. Aviat Space Environ Med 77:1230–1235

116.

Lee

Yen

Huang

Tzeng

, and Lin

. 2012a. Resveratrol Nanoparticle System Improves Dissolution Properties and Enhances the Hepatoprotective Effect of Resveratrol through Antioxidant and Anti-Inflammatory Pathways. J Agric Food Chem 60:4662–4671

117.

Lee

Choi

Han

, and Strano

. 2010. Coherence resonance in a single-walled carbon nanotube ion channel. Science 329:1320–1324

118.

Lee

Liu

Chongwu

, and Kosko

. 2006. Noise-Enhanced Detection of Subthreshold Signals With Carbon Nanotubes. Nanotechnology, IEEE Transactions on 5:613–627

119.

Lee

Browning

Nallathamby

Desai

Cherukuri

, and Xu

. 2012b. In vivo quantitative study of sized-dependent transport and toxicity of single silver nanoparticles using zebrafish embryos. Chem Res Toxicol 25:1029–1046

120.

Lenaghan

Burris

Chourey

Huang

Xia

Lady

Sharma

Pan

Lejeune

Foister

Hettich

Stewart

Jr. , and Zhang

. 2013. Isolation and chemical analysis of nanoparticles from English ivy (Hedera helix L.). J R Soc Interface 10:20130392

121.

Lim

Jang

Kim

Kang

Lee

, and Choi

. 2012. The effects of sub-lethal concentrations of silver nanoparticles on inflammatory and stress genes in human macrophages using cDNA microarray analysis. Biomaterials 33:4690–4699

122.

Lindsay

. 2010. Introduction to Nanoscience. Oxford

123.

Liu

Chen

, and Chang

. 2009. Transitional properties of starch colloid with particle size reduction from micro- to nanometer. J Colloid Interface Sci 339:117–124

124.

Liu

Randolph

, and Carpenter

. 2012. Particles shed from syringe filters and their effects on agitation-induced protein aggregation. J Pharm Sci 101:2952–2959

125.

Liu

Kathan

Saad

, and Prudhomme

. 2007. Ostwald ripening of B-carotene nanoparticles. Physical Review Letters 98:1–4

126.

Lloyd

. 2011. Quantum coherence in biological systems. Journal of Physics: Conference Series International Symposium “Nanoscience and Quantum Physics 2011”:012037

127.

Losada

. 1999. The complex dynamics of high performance teams. Mathematical Computer Modelling 30:179–192

128.

Losada

and Heaphy

. 2004. The role of positivity and connectivity in the performance of business teams: a nonlinear dynamics model. American Behavioral Scientist 47:740–765

129.

Tian

Zhao

Jin

Xiao

, and Fan

. 2011. Integrated metabonomics analysis of the size-response relationship of silica nanoparticles-induced toxicity in mice. Nanotechnology 22:055101

130.

Lunt

Barwood

Corbett

, and Tipton

. 2010. ‘Cross-adaptation’: habituation to short repeated cold-water immersions affects the response to acute hypoxia in humans. J Physiol 588:3605–3613

131.

Luther

Jain

Ewers

, and Alivisatos

. 2011. Localized surface plasmon resonances arising from free carriers in doped quantum dots. Nat Mater 10:361–366

132.

Magalhaes

and Kohn

. 2011. Vibratory noise to the fingertip enhances balance improvement associated with light touch. Experimental brain research. Experimentelle Hirnforschung. Experimentation cerebrale 209:139–151

133.

Mahony

Cavallaro

Stahr

Mahony

Qiao

, and Mitter

. 2013. Mesoporous Silica Nanoparticles Act as a Self-Adjuvant for Ovalbumin Model Antigen in Mice. Small 9:3138–46

134.

Malarczyk

Pazdzioch-Czochra

Graz

Kochmanska-Rdest

, and Jarosz-Wilkolazka

. 2011. Nonlinear changes in the activity of the oxygen-dependent demethylase system in Rhodococcus erythropolis cells in the presence of low and very low doses of formaldehyde. Nonlinear Biomed Phys 5:9

135.

McDonnell

and Abbott

. 2009. What Is Stochastic Resonance? Definitions, Misconceptions, Debates, and Its Relevance to Biology. PLoS Comput Biol 5:e1000348

136.

McGuinness

Yan

Stacey

Simpson

Hall

Maclaurin

Prawer

Mulvaney

Wrachtrup

Caruso

Scholten

, and Hollenberg

. 2011. Quantum measurement and orientation tracking of fluorescent nanodiamonds inside living cells. Nat Nanotechnol 6:358–363

137.

McKibbin

Scappucci

Pok

, and Simmons

. 2013. Epitaxial top-gated atomic-scale silicon wire in a three-dimensional architecture. Nanotechnology 24:045303

138.

Melancon

Zhou

, and Li

. 2011. Cancer theranostics with near-infrared light-activatable multimodal nanoparticles. Acc Chem Res 44:947–956

139.

Merisko-Liversidge

and Liversidge

. 2011. Nanosizing for oral and parenteral drug delivery: a perspective on formulating poorly-water soluble compounds using wet media milling technology. Adv Drug Deliv Rev 63:427–440

140.

Mihalik

and Csermely

. 2011. Heat shock partially dissociates the overlapping modules of the yeast protein-protein interaction network: a systems level model of adaptation. PLoS Comput Biol 7:e1002187

141.

Milisav

Poljsak

, and Suput

. 2012. Adaptive response, evidence of cross-resistance and its potential clinical use. Int J Mol Sci 13:10771–10806

142.

Mittal

Chisti

, and Banerjee

. 2013. Synthesis of metallic nanoparticles using plant extracts. Biotechnol Adv 31:346–56

143.

Moss

Ward

, and Sannita

. 2004. Stochastic resonance and sensory information processing: a tutorial and review of application. Clin Neurophysiol 115:267–281

144.

Moulari

Beduneau

Pellequer

, and Lamprecht

. 2013. Nanoparticle targeting to inflamed tissues of the gastrointestinal tract. Curr Drug Deliv 10:9–17

145.

Mudunkotuwa

and Grassian

. 2011. The devil is in the details (or the surface): impact of surface structure and surface energetics on understanding the behavior of nanomaterials in the environment. J Environ Monit 13:1135–1144

146.

Murdock

Braydich-Stolle

Schrand

Schlager

, and Hussain

. 2008. Characterization of nanomaterial dispersion in solution prior to in vitro exposure using dynamic light scattering technique. Toxicol Sci 101:239–253

147.

Nascarella

and Calabrese

. 2012. A method to evaluate hormesis in nanoparticle dose-responses. Dose Response 10:344–354

148.

Ning

and Chen

. 2006. Mild hypothermic cross adaptation resists hypoxic injury in hearts: a brief review. Chin J Physiol 49:213–222

149.

Osborne

Johnston

Moger

Balousha

Lead

Kudoh

, and Tyler

. 2012. Effects of particle size and coating on nanoscale Ag and TiO(2) exposure in zebrafish (Danio rerio) embryos. Nanotoxicology 7:1315–1324

150.

Oyewumi

Kumar

, and Cui

. 2010. Nano-microparticles as immune adjuvants: correlating particle sizes and the resultant immune responses. Expert Rev Vaccines 9:1095–1107

151.

Pandey

Thakur

Shah

Oza

Mewada

, and Sharon

. 2013. A comparative study of economical separation and aggregation properties of biologically capped and thiol functionalized gold nanoparticles: Selecting the eco-friendly trojan horses for biological applications. Colloids Surf B Biointerfaces 109:25–31

152.

Park

Noh

Han

Kim

Choi

Kim

, and Cho

. 2012. Artemisia capillaris extracts as a green factory for the synthesis of silver nanoparticles with antibacterial activities. J Nanosci Nanotechnol 12:7087–7095

153.

Petkar

Chavhan

Agatonovik-Kustrin

, and Sawant

. 2011. Nanostructured materials in drug and gene delivery: a review of the state of the art. Crit Rev Ther Drug Carrier Syst 28:101–164

154.

Pham

Fullston

, and Sagoe-Crentsil

. 2007. Surface modification for stability of nano-sized silica colloids. J Colloid Interface Sci 315:123–127

155.

Pickering

Vojtovich

Tower

, and Ad

. 2013. Oxidative stress adaptation with acute, chronic, and repeated stress. Free Radic Biol Med 55:109–118

156.

Pinamonti

Marro

, and Torres

. 2012. Stochastic resonance crossovers in complex networks. PLoS One 7:e51170

157.

Pincus

and Metten

. 2010. Nonlinear dynamics in biopsychosocial resilience. Nonlinear Dynamics Psychol Life Sci 14:353–380

158.

Prakash

Arulkumar

, and Sabesan

. 2010. Effect of nanohypericum (Hypericum perforatum gold nanoparticles) treatment on restraint stress induced behavioral and biochemical alteration in male albino mice. Pharmacognosy Res 2:330–334

159.

Raja

Satti

Liu

, and Castracane

. 2013. Dose Response of MTLn3 Cells to Serial Dilutions of Arsenic Trioxide and Ionizing Radiation. Dose Response 11:29–40

160.

Rao

El-Hami

Kodaki

Matsushige

, and Makino

. 2005. A novel method for synthesis of silica nanoparticles. J Colloid Interface Sci 289:125–131

161.

Richert

Servid

Harmsen

Rynda-Apple

Han

Wiley

Douglas

, and Harmsen

. 2012. A virus-like particle vaccine platform elicits heightened and hastened local lung mucosal antibody production after a single dose. Vaccine 30:3653–3665

162.

Ristorcelli

Beraud

Mathieu

Lombardo

, and Verine

. 2009. Essential role of Notch signaling in apoptosis of human pancreatic tumoral cells mediated by exosomal nanoparticles. Int J Cancer 125:1016–1026

163.

Rodrigues

Ajayan

, and Silva

. 2013. Fast vortex-assisted self-assembly of carbon nanoparticles on an air-water interface. J Phys Chem B 117:6524–6533

164.

Rodriguez

Snoek

Riksen

Bevers

, and Kammenga

. 2012. Genetic variation for stress-response hormesis in C. elegans lifespan. Exp Gerontol 47:581–587

165.

Roduner

. 2006. Size matters: why nanomaterials are different. Chemical Society Reviews 35:583–592

166.

Rowe

Jeong

Mkhoyan

, and Kortshagen

. 2013. Phosphorus-doped silicon nanocrystals exhibiting mid-infrared localized surface plasmon resonance. Nano Lett 13:1317–1322

167.

Ruan

and Jacobi

. 2012. Ultrasonication effects on thermal and rheological properties of carbon nanotube suspensions. Nanoscale Research Letters 7:127

168.

Salavati-Niasari

Javidi

, and Dadkhah

. 2012. Ball milling synthesis of silica nanoparticle from rice husk ash for drug delivery application. Comb Chem High Throughput Screen 16:458–62

169.

Sandberg

Lag

Holme

Friede

Gualtieri

Kruszewski

Schwarze

Skuland

, and Refsnes

. 2012. Comparison of non-crystalline silica nanoparticles in IL-1beta release from macrophages. Part Fibre Toxicol 9:32

170.

Sayed

Al-Sadoon

, and Badr

. 2012. Silica Nanoparticles Sensitize Human Multiple Myeloma Cells to Snake (Walterinnesia aegyptia) Venom-Induced Apoptosis and Growth Arrest. Oxidative medicine and cellular longevity 2012:386286

171.

Schiff

Jerger

Duong

Chang

Spano

, and Ditto

. 1994. Controlling chaos in the brain. Nature 370:615–620

172.

Shalchian

Grisolia

Assayag

Coffin

Atarodi

, and Claverie

. 2005. Room-temperature quantum effect in silicon nanoparticles obtained by low-energy ion implantation and embedded in a nanometer scale capacitor. Applied Physics Letters 86:163111–163113

173.

Shannahan

Kodavanti

, and Brown

. 2012. Manufactured and airborne nanoparticle cardiopulmonary interactions: a review of mechanisms and the possible contribution of mast cells. Inhal Toxicol 24:320–339

174.

Shi

Zhang

Jiang

Zhu

Tan

, and Lu

. 2010a. Synergistic genotoxicity caused by low concentration of titanium dioxide nanoparticles and p,p'-DDT in human hepatocytes. Environ Mol Mutagen 51:192–204

175.

Shi

Huang

Liu

Tao

Cai

, and Tang

. 2010b. Biological response of osteosarcoma cells to size-controlled nanostructured hydroxyapatite. J Biomater Appl 25:19–37

176.

Shirali

Look

Kassis

Stout-Delgado

Fahmy

, and Goldstein

. 2011. Nanoparticle delivery of mycophenolic acid upregulates PD-L1 on dendritic cells to prolong murine allograft survival. American journal of transplantation: official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 11:2582–2592

177.

Siddiqi

Abdelhalim

El-Ansary

Alhomida

, and Ong

. 2012. Identification of potential biomarkers of gold nanoparticle toxicity in rat brains. J Neuroinflammation 9:123

178.

Singh

Jagannathan

Khandelwal

Abraham

, and Poddar

. 2013. In situ synthesis and surface functionalization of gold nanoparticles with curcumin and their antioxidant properties: an experimental and density functional theory investigation. Nanoscale 5:1882–1893

179.

Snitka

Naumenko

Ramanauskaite

Kravchenko

, and Snopok

. 2012. Generation of diversiform gold nanostructures inspired by honey's components: Growth mechanism, characterization, and shape separation by the centrifugation-assisted sedimentation. J Colloid Interface Sci 386:99–106

180.

Song

Yang

Jiang

, and Xing

. 2012. Adsorption of bovine serum albumin on nano and bulk oxide particles in deionized water. Colloids Surf B Biointerfaces 94:341–346

181.

Sorg

Tschirgi

Swindell

Chen

, and Fang

. 2001. Repeated formaldehyde effects in an animal model for multiple chemical sensitivity. Annals of the New York Academy of Sciences. 933:57–67

182.

Sorg

Willis

See

Hopkins

, and Westberg

. 1998. Repeated low-level formaldehyde exposure produces cross-sensitization to cocaine: possible relevance to chemical sensitivity in humans. Neuropsychopharmacology 18:385–394

183.

Soti

and Csermely

. 2003. Aging and molecular chaperones. Exp Gerontol 38:1037–1040

184.

Soti

and Csermely

. 2006. Pharmacological modulation of the heat shock response. Handb Exp Pharmacol:417–436

185.

Soti

and Csermely

. 2007. Aging cellular networks: chaperones as major participants. Exp Gerontol 42:113–119

186.

Soumya

Ghosh

, and Abraham

. 2010. Preparation and characterization of guar gum nanoparticles. Int J Biol Macromol 46:267–269

187.

Stark

. 2012. The sandpile model: optimal stress and hormesis. Dose Response 10:66–74

188.

Stark

. 2011. Nanoparticles in biological systems. Angew Chem Int Ed Engl 50:1242–1258

189.

Stovbun

Kiselev

Zanin

Kalinina

Voronina

Mikhailov

, and Berlin

. 2012. Effects of physicochemical forms of phenazepam and Panavir on their action at ultra-low doses. Bull Exp Biol Med 153:455–458

190.

Sugarman

Tsai

Santamaria

, and Khadra

. 2013. Quantifying the importance of pMHC valency, total pMHC dose and frequency on nanoparticle therapeutic efficacy. Immunol Cell Biol 91:350–359

191.

Sun

Chen

Dong

Liu

Qiu

Wan

, and Li

. 2012. Influences of surface coatings and components of FePt nanoparticles on the suppression of glioma cell proliferation. Int J Nanomedicine 7:3295–3307

192.

Sur

Altunbek

Kahraman

, and Culha

. 2012. The influence of the surface chemistry of silver nanoparticles on cell death. Nanotechnology 23:375102

193.

Sur

Cam

Kahraman

Baysal

, and Culha

. 2010. Interaction of multi-functional silver nanoparticles with living cells. Nanotechnology 21:175104

194.

Suriyakalaa

Antony

Suganya

Siva

Sukirtha

Kamalakkannan

Pichiah

, and Achiraman

. 2012. Hepatocurative activity of biosynthesized silver nanoparticles fabricated using Andrographis paniculata. Colloids Surf B Biointerfaces 102C:189–194

195.

Szalay

Kovacs

Korcsmaros

Bode

, and Csermely

. 2007. Stress-induced rearrangements of cellular networks: Consequences for protection and drug design. FEBS Lett 581:3675–3680

196.

Tang

Zhou

Yang

Zhang

Chen

, and Yang

. 2011. Wet-grinding assisted ultrasonic dispersion of pristine multi-walled carbon nanotubes (MWCNTs) in chitosan solution. Colloids Surf B Biointerfaces 86:189–197

197.

Tang

Zhang

Xue

Wang

Huang

Yang

Lei

Kong

, and Yuepu

. 2010. Dose dependent in vivo metabolic characteristics of titanium dioxide nanoparticles. J Nanosci Nanotechnol 10:8575–8583

198.

Tantra

Tompkins

, and Quincey

. 2010. Characterisation of the de-agglomeration effects of bovine serum albumin on nanoparticles in aqueous suspension. Colloids Surf B Biointerfaces 75:275–281

199.

Thurber

Wingett

Rasmussen

Layne

Johnson

Tenne

Zhang

Hanna

, and Punnoose

. 2012. Improving the selective cancer killing ability of ZnO nanoparticles using Fe doping. Nanotoxicology 6:440–452

200.

Torres

and Ruiz

MAG

. 1996. Stochastic resonance and the homeopathic effect. British Homoeopathic Journal 85(3):134–140

201.

Tournebize

Boudier

Joubert

Eidi

Bartosz

Maincent

Leroy

, and Sapin-Minet

. 2012. Impact of gold nanoparticle coating on redox homeostasis. Int J Pharm 438:107–116

202.

Tripathi

Chandrasekaran

Raichur

, and Mukherjee

. 2009. Antibacterial applications of silver nanoparticles synthesized by aqueous extract of Azadirachta indica (Neem) leaves. J Biomed Nanotechnol 5:93–98

203.

Troia

Giovannozzi

, and Amato

. 2009. Preparation of tunable silicon q-dots through ultrasound. Ultrason Sonochem 16:448–451

204.

Truong

Tilton

Zaikova

Richman

Waters

Hutchison

, and Tanguay

. 2013. Surface functionalities of gold nanoparticles impact embryonic gene expression responses. Nanotoxicology 7:192–201

205.

Umashankari

Inbakandan

Ajithkumar

, and Balasubramanian

. 2012. Mangrove plant, Rhizophora mucronata (Lamk, 1804) mediated one pot green synthesis of silver nanoparticles and its antibacterial activity against aquatic pathogens. Aquatic biosystems 8:11

206.

Vaiserman

. 2010. Hormesis, adaptive epigenetic reorganization, and implications for human health and longevity. Dose Response. 8:16–21

207.

Vaiserman

. 2011. Hormesis and epigenetics: is there a link? Ageing Res Rev 10:413–421

208.

Van Hoecke

De Schamphelaere

Ramirez-Garcia

Van der Meeren

Smagghe

, and Janssen

. 2011. Influence of alumina coating on characteristics and effects of SiO2 nanoparticles in algal growth inhibition assays at various pH and organic matter contents. Environ Int 37:1118–1125

209.

Van Hoecke

De Schamphelaere

Van der Meeren

Lucas

, and Janssen

. 2008. Ecotoxicity of silica nanoparticles to the green alga Pseudokirchneriella subcapitata: importance of surface area. Environ Toxicol Chem 27:1948–1957

210.

Van Wijk

and Wiegant

. 2010. Postconditioning hormesis and the homeopathic Similia principle: molecular aspects. Hum Exp Toxicol 29:561–565

211.

Van Wijk

and Wiegant

. 2011. Postconditioning hormesis and the similia principle. Front Biosci (Elite Ed) 3:1128–1138

212.

Vesterdal

Folkmann

Jacobsen

Sheykhzade

Wallin

Loft

, and Moller

. 2010. Pulmonary exposure to carbon black nanoparticles and vascular effects. Part Fibre Toxicol 7:33

213.

Vijayaraghavan

and Nalini

. 2010. Biotemplates in the green synthesis of silver nanoparticles. Biotechnol J 5:1098–1110

214.

Vivero-Escoto

Slowing II Trewyn

, and Lin

. 2010. Mesoporous silica nanoparticles for intracellular controlled drug delivery. Small 6:1952–1967

215.

Wang

and Thanou

. 2010. Targeting nanoparticles to cancer. Pharmacol Res 62:90–99

216.

Wang

Bao

Ahire

, and Chao

. 2012a. Co-encapsulation of Biodegradable Nanoparticles with Silicon Quantum Dots and Quercetin for Monitored Delivery. Advanced healthcare materials 2:459–66

217.

Wang

Jiang

Zhao

Wang

Zou

, and Cheng

. 2012b. Enhanced mucosal and systemic immune responses obtained by porous silica nanoparticles used as an oral vaccine adjuvant: Effect of silica architecture on immunological properties. Int J Pharm 436:351–358

218.

Wang

Luo

Wang

Efferth

, and Zu

. 2013. Glycyrrhizic acid nanoparticles inhibit LPS-induced inflammatory mediators in 264.7 mouse macrophages compared with unprocessed glycyrrhizic acid. Int J Nanomedicine 8:1377–1383

219.

Wang

and Chen

. 2011. Quantum dots, lighting up the research and development of nanomedicine. Nanomedicine 7:385–402

220.

Wiegant

Prins

, and Van Wijk

. 2011. Postconditioning hormesis put in perspective: an overview of experimental and clinical studies. Dose Response 9:209–224

221.

Wiegant

Spieker

, and van Wijk

. 1998. Stressor-specific enhancement of hsp induction by low doses of stressors in conditions of self- and cross-sensitization. Toxicology 127:107–119

222.

Winnik

and Maysinger

. 2013. Quantum Dot Cytotoxicity and Ways To Reduce It. Acc Chem Res 46:672–680

223.

Wong

. 2011. Oral fast-release solid dispersion-paradigm shift to nanoparticles. Recent Pat Drug Deliv Formul 5:227–243

224.

Xia

Xiong

Lim

, and Skrabalak

. 2009. Shape-controlled synthesis of metal nanocrystals: simple chemistry meets complex physics? Angew Chem Int Ed Engl 48:60–103

225.

Yang

Yuan

, and Shi

. 2011. Investigation of the enhancement fluorescence of ethanol doped SiO2 nanoparticles. J Nanosci Nanotechnol 11:9717–9720

226.

Yao

and Hughes

. 2009. Macroscopic entanglement and violation of Bell's inequalities between two spatially separated quantum dots in a planar photonic crystal system. Opt Express 17:11505–11514

227.

Yen

Lin

Cham

, and Lin

. 2008. Nanoparticles formulation of Cuscuta chinensis prevents acetaminophen-induced hepatotoxicity in rats. Food Chem Toxicol 46:1771–1777

228.

Yoo

Lee

Shin

, and Cheon

. 2011. Theranostic magnetic nanoparticles. Acc Chem Res 44:863–874

229.

Yoo

Yun

, and Kim

. 2006. Influence of reaction parameters on size and shape of silica nanoparticles. J Nanosci Nanotechnol 6:3343–3346

230.

Wang

Deng

Wei

, and Liu

. 2013. Effects of time delay on the stochastic resonance in small-world neuronal networks. Chaos 23:013128

231.

Zhang

Kuang

Zhao

, and Chai

. 2011. Nano-CeO2 exhibits adverse effects at environmental relevant concentrations. Environ Sci Technol 45:3725–3730

232.

Zhang

Chen

Schwehr

Quigg

Chin

Santschi

Spurgin

, and Jiang

. 2012. Aggregation, Dissolution and Stability of Quantum Dots in Marine Environments: The Importance of Extracellular Polymeric Substances. Environ Sci Technol 46:8764–72

233.

Zhao

and Feng

. 2010. Enhanced oral bioavailability of paclitaxel formulated in vitamin E-TPGS emulsified nanoparticles of biodegradable polymers: in vitro and in vivo studies. J Pharm Sci 99:3552–3560

234.

Zhao

Peng

Hernandez-Viezcas

Rico

Sun

Peralta-Videa

Tang

Niu

Jin

Varela-Ramirez

Zhang

, and Gardea-Torresdey

. 2012. Stress Response and Tolerance of Zea mays to CeO(2) Nanoparticles: Cross Talk among H(2)O(2), Heat Shock Protein, and Lipid Peroxidation. ACS Nano 6:9615–22

235.

Zhou

and Lee

. 2011. Nanoscale hydroxyapatite particles for bone tissue engineering. Acta Biomater 7:2769–2781

236.

Zhu

Shi

Feng

Nie

, and Zhao

. 2012a. Exosomes as extrapulmonary signaling conveyors for nanoparticle-induced systemic immune activation. Small 8:404–412

237.

Zhu

Tian

Song

Tian

Zhao

, and Nie

. 2012b. Nanoparticle-Induced Exosomes Target Antigen-Presenting Cells to Initiate Th1-Type Immune Activation. Small 8:2841–2848

238.

Zhu

Oberdorster

, and Haasch

. 2006. Toxicity of an engineered nanoparticle (fullerene, C60) in two aquatic species, Daphnia and fathead minnow. Mar Environ Res 62 Suppl:S5–9

Nonlinear Effects of Nanoparticles: Biological Variability from Hormetic Doses,Small Particle Sizes,and Dynamic Adaptive Interactions

Abstract

Keywords

INTRODUCTION

APPLICATIONS IN MEDICINE AND TOXICOLOGY

HORMESIS AND NANOPARTICLES

UNIQUE FEATURES OF NANOPARTICLES

Nonlinearity from Nanoparticle Properties: Beyond Hormetic Dose-Response Relationships

Quantum Properties of Nanoparticles

Interactions of NPs with the Organism as a Complex Adaptive System or Network

CONCLUSIONS

References